Researchers has significantly boosted its course of the novel therapy for ATTR-CM, leveraging Attruby. Preliminary clinical data indicates significant improvements for those suffering by a severe illness. The focus represents BridgeBio's focus to addressing unmet medical demands in a heart disease space. Attruby: BridgeBio's Novel Appro… Read More